Retension Pharmaceuticals, Inc. (RTSN) stock
RTSNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$12.27+0.02 (+0.16%)
Close on Nov 13, 2026Market cap –P/E –Yield –
Key statistics
Valuation at the latest close; fundamentals over fiscal
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Trading
- Previous close
- $12.25
- Open
- $12.30
- Day's range
- $11.37 – $12.70
- Volume
- 124,992
- Average volume (20 days)
- 114,240
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | RTSN | S&P 500 | Difference | RTSN per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +5.5% | -3.0% | +8.5 pts |
Retension Pharmaceuticals stock: common questions
What is Retension Pharmaceuticals's stock price?
RTSN closed at $12.27 on Nov 13, 2026, up 0.16% on the day.
Does Retension Pharmaceuticals pay a dividend?
No. Retension Pharmaceuticals has not paid a cash dividend over the last twelve months.
Who are Retension Pharmaceuticals's competitors?
Companies most similar to Retension Pharmaceuticals by business, industry and size include LLY, JNJ, ABBV, MRK, AZN.
See a number that looks wrong?